CA
NZ
UK
AU
IND
US
Market Movers :On Friday, the top gainers were Brand Engagement Network Inc. (+62.50%), followed by Atlantic International Corp. (+53.38%). On the contrary, ESH Acquisition Corp. (-20.49%), and Laser Photonics Corporation (-19.03%) declined the most the same day.
Aptiv PLC (NYSE:APTV), a global industrial technology company, announced it will present its latest intelligent edge solutions at CES 2026, illustrating how devices can sense, think, and act in real time while optimizing performance throughout their lifecycle. The company said its approach brings advanced …
Kosmos Energy (NYSE:KOS) has released an operational and financial update outlining recent developments across its portfolio, including progress in Ghana, Mauritania and Senegal, alongside updates on financing activities.
argenx SE (NASDAQ:ARGX) has announced a series of planned leadership transitions involving its executive team and Board of Directors. The company said current Chief Operating Officer Karen Massey will move into the role of Chief Executive Officer and Executive Director, while current Chief Executive …
SEALSQ Corp (NASDAQ:LAES), a company engaged in semiconductor, PKI, and post-quantum technology hardware and software, has announced that its senior leadership will undertake a strategic roadshow across India in early January. The initiative will be led by Founder and Chief Executive Officer Carlos Moreira …
Wall Street Zenrecently updated its assessment ofArcutis Biotherapeutics Inc. (NASDAQ:ARQT), upgrading the stock from abuyrating to astrong-buyrating in a report released on Sunday. The change followed a series of analyst updates tied to earnings performance and broader sector developments.
In a recent research note,Wall Street Zenrevised its rating onASE Technology Holding Co., Ltd. (NYSE:ASX), downgrading the stock frombuytohold. The update, released on Sunday, reflects a reassessment of the company’s positioning based on recent developments and broader sector conditions.
HUTCHMED Limited (Nasdaq:HCM) has initiated the Phase III segment of its ongoing Phase II/III trial evaluating the combination of surufatinib, camrelizumab, nab-paclitaxel, and gemcitabine (S+C+AG) as a first-line treatment for patients with metastatic pancreatic ductal adenocarcinoma (PDAC) in China. The first patient in this …
Market Movers:On thefinal trading day of 2025, U.S. equities closed mixed as investors wrapped up a volatile year. Among thetop gainers,Nvidia Corprose over2%, continuing its strong momentum from AI-driven demand, whileMeta Platformsadvanced nearly1.5%on optimism around advertising growth. On the downside,Tesla Incslipped more than3%as concerns …
Mesoblast Limited (NASDAQ:MESO; ASX: MSB) announced a series of board changes following its recent Annual General Meeting, as part of an update to its governance structure aligned with the company’s transition toward a revenue-generating commercial phase.
Please wait processing your request...